DekaBank Deutsche Girozentrale

DekaBank Deutsche Girozentrale’s 4D Molecular Therapeutics FDMT Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio FDMT Stock Details FDMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$261K	Hold	30,000	–	–	﹤0.01%	948
2025 Q4	$1.17M	Hold	30,000	–	–	﹤0.01%	846
2025 Q3	$1.16M	Hold	30,000	–	–	﹤0.01%	843
2025 Q2	$1.17M	Hold	30,000	–	–	﹤0.01%	831
2025 Q1	$1.08M	Hold	30,000	–	–	﹤0.01%	834
2024 Q4	$1.02M	Hold	30,000	–	–	﹤0.01%	872
2024 Q3	$1.08M	Hold	30,000	–	–	﹤0.01%	871
2024 Q2	$1.08M	Hold	30,000	–	–	﹤0.01%	862
2024 Q1	$1.08M	Sell	30,000 -16,000	-35%	-$408K	﹤0.01%	862
2023 Q4	$966K	Buy	+46,000	New	+$605K	﹤0.01%	905

Other funds holding FDMT

Janus Henderson Group

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return